We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: suPARnostic Quick Triage kit is used in POC situation for early warning and patient triaging (Photo courtesy of ViroGates)

POC Critical Illness Test Designed for Early Warning and Patient Triaging

An easy-to-use, quantitative test for early warning and patient triaging measures levels of the prognostic biomarker suPAR to allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome. More...
31 May 2022
Image: A biomarker will enable Parkinson’s disease to be diagnosed from blood samples (Photo courtesy of Unsplash)

World’s First Biomarker Can Diagnose Parkinson's Disease from Blood Serum Samples

In a world-first, researchers have succeeded in developing a biomarker that can be used to easily and inexpensively assess Parkinson’s disease. More...
30 May 2022
DIASOURCE (A Biovendor Company)
Image: Noninvasive technique collects sufficient tear fluid to look for biomarkers of health and disease (Photo courtesy of Unsplash)

Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases

Researchers have found that the same tissue paper, called a Schirmer strip, already placed painlessly against the eye to measure tear production in patients, can also capture a sufficient volume of tear fluid for a detailed protein analysis. More...
30 May 2022
Image: New pan-cancer companion diagnostic matches patients with rare genetic mutations to targeted therapy (Photo courtesy of Illumina)

Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy

Most companion diagnostic (CDx) tests are specific to one type of cancer, but a new CDx test allows for identification of cancer patients with solid tumors who are positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusions, including NTRK1, NTRK2 or NTRK3. More...
30 May 2022
Image: LumiraDx HbA1c test has achieved CE mark (Photo courtesy of LumiraDx)

LumiraDx HbA1c Assay Screens and Identifies Patients at Risk for Developing Diabetes

A new rapid microfluidic immunofluorescence assay is designed to address the growing clinical need for accessible and reliable HbA1c testing in the community healthcare setting. More...
30 May 2022
Image: SAMBA II is a real game changer in infectious disease management (Photo courtesy of DRW)

POC System Could Transform Infectious Disease Management

A new platform supports rapid, efficient and accurate diagnosis of multiple infectious diseases, aiding clinical decision-making, and enabling improved, timely access to healthcare for all. More...
27 May 2022
Image: Aristotle blood test detects molecular signatures of multiple cancers from single blood sample (Photo courtesy of StageZero Life Sciences)

mRNA Test Screens for Multiple Cancers from Single Blood Sample

Late stage cancer diagnosis can be attributed to many factors. Now, a new blood test that detects the molecular signatures of multiple cancers from a single sample of blood could help find cancer earlier. More...
27 May 2022
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Host Response Immunoassay Test
MeMed BV


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
PURITAN MEDICAL